NAD+ and peptide COA verification behind the product trail.
Clinic Terrain connects the patient, the physician’s decision, the exact presentation and its analytical evidence. These four QR-verified records are genuine Chromate entries. Each record remains bounded to the molecule, presentation and measurements stated by the laboratory.
04 published records03 named molecules01 independent laboratory
What reassures a serious patient
A real analytical record, read at the scope the laboratory actually tested.
Each QR code was decoded and each direct link was checked against Chromate’s live database. Every link below opens the exact laboratory job and its downloadable certificate.
Publication and product release are separate decisions. Before a product is described as batch-traced, the precise presentation and lot being proposed must be reconciled with applicable documentation during the clinical release step.
The verification scope is limited to the measurements named on each laboratory record. Other release controls are assessed separately.
Verified analytical set
What was tested, and how far the proof travels.
NAD+ has two relevant 500mg references. Tirzepatide and retatrutide have authentic records, but each result remains specific to the tested presentation and cannot be transferred to a different product.
01 · QR VERIFIEDNAD+ analytical reference · exact product match required
The physician selects, refuses or postpones the molecule.
02Exact presentation
Molecule, form and strength must match.
03Current lot
The vial or cartridge must carry a resolvable lot.
04Matching analysis
The laboratory record must apply to that presentation and lot.
05Receipt and storage
Origin, arrival and handling remain documented.
06Patient record
The released product stays connected to dose and follow-up.
Product-specific verification
Documentation matched to the product, not borrowed from another molecule.
Certificates are linked only to the exact molecule and presentation tested. For BPC-157, GHK-Cu and TB-500, no general certificate is borrowed from the records above. Any proposed product requires its own source-, presentation- and batch-specific documentation review.